Baganday, Nasroddin L.
HRN: 07-99-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2025
CEFTRIAXONE 1G (VIAL)
03/03/2025
03/10/2025
IV
2gms
Od
Pnenumona
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes